Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Endometrium Cancer

Interventions

DRUG

Provera

Progesterone Challenge Test

Trial Locations (1)

VGH Research Pavilion, Vancouver

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Canadian Cancer Society (CCS)

OTHER

lead

University of British Columbia

OTHER